3D Bioprinting Market Size to Touch Valuation of $1.5 Billion by 2028 | Inkjet Technology Generates More than 38% Revenue of Bioprinting Market
09 oct. 2022 19h44 HE
|
Vantage Market Research
WASHINGTON, Oct. 09, 2022 (GLOBE NEWSWIRE) -- Global 3D bioprinting market was valued at USD 1.5 Billion in 2021 and is projected to attain a value of USD 3.7 Billion by 2028 during the forecast...
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
06 sept. 2022 08h20 HE
|
Organovo, Inc.
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), an early-stage biotechnology company that is focusing on building high fidelity, 3D tissues that recapitulate...
Transplantation Market Size is projected to reach USD 29.73 Billion by 2030, growing at a CAGR of 9.55 %: Straits Research
11 août 2022 15h20 HE
|
Straits Research
New York, United States, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The global increase in the demand for organs for transplant can be attributed to increasing incidences of acute diseases, which in turn...
3D Printing Medical Devices Market Size Worth $6,583.50 million by 2028 to Rise at a Stellar CAGR of 17.5% by 2028, Says The Insight Partners
07 juin 2022 08h30 HE
|
The Insight Partners
New York, June 07, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "3D Printing Medical Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by...
Organovo Achieves 3D Tissue Model for Crohn’s Disease
17 mai 2022 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional (3D) biology company focused on delivering scientific and medical breakthroughs using novel...
Global 3D Bioprinting Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
14 avr. 2022 07h43 HE
|
Research and Markets
Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
01 mars 2022 08h05 HE
|
Organovo, Inc.
SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO (OTCPK: CLLKF, Nasdaq Stockholm: BICO.ST) announced they have reached agreement on a broad license for...
Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
23 févr. 2022 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO today announced they have reached agreement on a broad license for BICO and its affiliate companies to...
Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 févr. 2022 16h00 HE
|
Organovo, Inc.
SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo”), today announced that it has granted a stock option to purchase 50,000 shares of common stock to one...
Organovo Welcomes New Sr. Vice President of Strategy and Business Development
18 févr. 2022 13h00 HE
|
Organovo, Inc.
SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using 3D...